|
Real-time Estimate
Cboe Europe
07:26:54 2026-11-02 am EST
|
5-day change | 1st Jan Change | ||
| 13,818.00 GBX | -1.02% |
|
+7.66% | +0.35% |
| 07:25am | RBC Raises Price Target on AstraZeneca to GBP152.50 From GBP145, Keeps Outperform Rating | MT |
| 07:08am | AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating | ZD |
| Market Cap | 290B 260B 239B 217B 405B 27,543B 412B 2,850B 1,144B 14,488B 1,089B 1,065B 45,691B | P/E 2026 * |
24.4x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 311B 279B 256B 232B 434B 29,557B 442B 3,058B 1,228B 15,548B 1,168B 1,143B 49,033B | EV / Sales 2026 * |
4.92x | EV / Sales 2027 * | 4.52x |
| Free-Float |
96.62% | Yield 2026 * |
1.77% | Yield 2027 * | 1.89% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Tradegate
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | -1.05% | ||
| 1 week | +7.66% | ||
| Current month | -0.87% | ||
| 1 month | +16.58% | ||
| 3 months | +20.33% | ||
| 6 months | +3.81% | ||
| Current year | +0.35% |
| 1 week | 12,642 |  | 14,002 |
| 1 month | 11,716 | | 14,002 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,090.32 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/6/26 | Free | See remarks | 2 | 0.0000% | - | |
| 9/14/26 | Free | Chief Financial Officer | 73 | 0.0000% | ||
| 9/14/26 | Buy | Chairman | 2,500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | +7.66% | +11.92% | +33.55% | 290B | |
| +3.19% | +11.31% | +64.28% | +155.66% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +83.74% | 658B | |
| +1.41% | +3.24% | +35.25% | +106.98% | 521B | |
| -1.57% | +0.08% | +52.91% | +66.62% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.38% | 369B | |
| -1.58% | +3.20% | +32.22% | +55.40% | 307B | |
| +1.15% | +6.09% | +56.15% | +78.66% | 252B | |
| +3.06% | +9.38% | +42.48% | +112.84% | 212B | |
| -0.50% | +1.52% | -16.14% | -62.73% | 175B | |
| Average | +0.09% | +5.54% | +39.76% | +67.61% | 443.74B | |
| Weighted average by Cap. | +0.16% | +6.43% | +47.44% | +92.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.3B 56.7B 52.15B 47.25B 88.33B 6,011B 89.98B 622B 250B 3,162B 238B 233B 9,971B | 67.3B 60.27B 55.44B 50.23B 93.9B 6,390B 95.66B 661B 265B 3,361B 253B 247B 10,600B |
| Net income | 11.73B 10.51B 9.67B 8.76B 16.37B 1,114B 16.68B 115B 46.28B 586B 44.04B 43.1B 1,848B | 13.66B 12.23B 11.25B 10.2B 19.06B 1,297B 19.42B 134B 53.87B 682B 51.27B 50.18B 2,152B |
| Net Debt | 21.22B 19B 17.48B 15.84B 29.61B 2,015B 30.16B 208B 83.68B 1,060B 79.63B 77.94B 3,342B | 14B 12.54B 11.53B 10.45B 19.53B 1,329B 19.9B 138B 55.2B 699B 52.53B 51.41B 2,205B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | GBX 13,824.12 | -0.97% | 414,424 |
| 26-10-30 | GBX 13,960.00 | +6.96% | 4,486,055 |
| 26-10-29 | GBX 13,052.00 | +2.26% | 1,421,354 |
| 26-10-28 | GBX 12,764.00 | -0.45% | 1,182,725 |
| 26-10-27 | GBX 12,822.00 | -0.25% | 2,232,524 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
